DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Protective Effects of Interleukin-1 Inhibition With Anakinra in Mouse Models of Ischemic Stroke With and Without Reperfusion
Severe brain ischemia is associated with life-threatening edema and inflammation. Interleukin-1 is a crucial mediator of inflammation, and its blockade showed benefits in experimental stroke. We studied anakinra, a modified recombinant human interleukin-1 receptor antagonist, in mouse models of moderate to severe ischemia/reperfusion and large hemispheric infarctions. Due to anakinra's short half-life, we used a novel subcutaneous infusion protocol and tested 2 drug doses., Study funded by Instituto de Salud Carlos III, Ministerio de Salud (grant PI21/00966 to Dr Urra); Ministerio de Ciencia, Innovación y Universidades MCIN/AEI/10.13039/501100011033 and “ERDF: A way of making Europe” by the “European Union” (grants PID2020‐113202RB‐I00 and PID2023‐150949OB‐I00 to Dr Planas, and grant PID2021‐125106OB‐C31 to Dr Arostegui); “Fundació La Marató de TV3” (grant 202330‐10) to Dr Planas, and the RICORS‐Ictus network of Instituto de Salud Carlos III (RD21/0006/0013 and RD24‐0009‐0002 to Dr Chamorro and RD21/0006/0014 and RD24‐0009‐0003 to Dr Salom)., Peer reviewed
Proyecto:
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2020-113202RB-I00
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2023-150949OB-I00
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2021-125106OB-C31
DOI: http://hdl.handle.net/10261/403776, https://api.elsevier.com/content/abstract/scopus_id/105004827308
HANDLE: http://hdl.handle.net/10261/403776, https://api.elsevier.com/content/abstract/scopus_id/105004827308